Obstructive Airway Diseases: Role of Lipid Mediators - Image 1

£174.80

CRC Press Obstructive Airway Diseases: Role of Lipid Mediators

Name: Obstructive Airway Diseases: Role of Lipid Mediators
Brand: CRC Press
Price: 174.8 GBP
Availability: InStock

Pharmacy - Dispensing

Price History & Forecast

Last 21 days • 21 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 21 days • 1 price levels

Days at Price

Price Analysis

Most common price: £175 (21 days, 100.0%)

Price range: £175 - £175

Price levels: 1 different prices over 21 days

Description

Incidences of inflammatory airway diseases are on the rise across the world. Existing therapeutic options are ineffective, unsafe, and expensive, and severe cases are nonresponsive to conventional therapy. Therefore, it is imperative that research be undertaken to discover new treatment options. Obstructive Airway Diseases: Role of Lipid Mediators discusses clinically successful and potential lipid targets that can make a difference in treating some of the most intractable disease states. Topics discussed include: Obstructive airway diseases, etiology, pathophysiology, and existing therapeutic options What constitutes a lipid and how it is broken down to generate biologically active mediators The role of enzymes in the process of lipid mediator synthesis The biology of arachidonic acid, platelet-activating factor, and lysophosphatidic acid and the role they play in airway inflammation Products of arachidonic acid metabolism such as leukotrienes, prostaglandins, epieicosatrienoic acid, and oxoeicosatetraenoic acid Proresolution lipid mediators in inflammatory airway disease conditions The role of sphingosine and ceramide in inflammatory airway disease Protein kinases activated by lipid mediators and those that trigger the generation of lipid messengers The combined input of a panel of international authorities on lipid mediators makes this volume a valuable resource for all those involved in researching, teaching, and studying airway inflammation as well as those involved in drug discovery research. Punit Srivastava maintains a blog with additional information about the book and his work.

Product Specifications

Brand: CRC Press
Format: Hardcover
ASIN: 1439851409
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Allied Health Professions > Pharmacy - Dispensing
Domain: Amazon UK
Release Date: 23 February 2012
Listed Since: 27 May 2011

Barcode

No barcode data available

CRC Press Obstructive Airway Diseases: Role of Lipid Mediators

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Pharmacology and Therapeutics of Airway Disease: 234 (Lung Biology in Health and Disease)

Lung Inflammation in Health and Disease, Volume I: 1303 (Advances in Experimental Medicine and Biology, 1303)

Druggable Lipid Signaling Pathways: 1274 (Advances in Experimental Medicine and Biology, 1274)

Pharmacology and Therapeutics of Airway Disease

Inflammatory Mechanisms in Asthma: 117 (Lung Biology in Health and Disease)

Adipose Tissue and Inflammation: 28 (Oxidative Stress and Disease)

CRC Press Inhaled Steroids in Asthma - Lung Biology Series

Pediatric Asthma: 126 (Lung Biology in Health and Disease)

Lung Inflammation in Health and Disease, Volume II: 1304 (Advances in Experimental Medicine and Biology, 1304)

Pathobiology of Pulmonary Disorders: 955 (Advances in Experimental Medicine and Biology, 955)

Lipid Mediators and Their Metabolism in the Brain

CRC Press - Lipid Oxidation in Health and Disease Book

Pulmonary Infection and Inflammation: 935 (Advances in Experimental Medicine and Biology, 935)

Inflammation, Lifestyle and Chronic Diseases: The Silent Link: 29 (Oxidative Stress and Disease)

Molecular Basis of Pulmonary Disease: Insights from Rare Lung Disorders (Respiratory Medicine)

Lung Inflammation in Health and Disease, Volume II: 1304 (Advances in Experimental Medicine and Biology, 1304)

Pulmonology: 1222 (Advances in Experimental Medicine and Biology, 1222)

Inflammatory Cells and Mediators in Bronchial Asthma: 1 (Handbooks in Pharmacology and Toxicology)

Lipid Metabolism and Health

Pulmonary Disorders and Therapy: 1023 (Advances in Experimental Medicine and Biology, 1023)

Purinergic Regulation of Respiratory Diseases: 55 (Subcellular Biochemistry, 55)

CRC Press New and Exploratory Therapeutic Agents for Asthma

Respiratory System Diseases: 980 (Advances in Experimental Medicine and Biology, 980)

Oxidative Stress and Inflammatory Mechanisms in Obesity, Diabetes, and the Metabolic Syndrome: 22 (Oxidative Stress and Disease)